Cardica, Inc. (CRDC) Announces Publication of Case Report in the Journal of Neurosurgery Featuring Use of C-Port(R) System in Brain Arterial Bypass - Dr. Ralph G. Dacey, Jr., Successfully Uses C-Port System to Bypass Cerebral Aneurysm in Patient with Brain Injury - 11/10/2008
More...
|
Allon Therapeutics, Inc. Releases Phase II MCI-CABG Results 8/29/2008
More...
|
Biomaterial and Tissue Engineering Centre (BTEC), Royal Free and University College Medical School, and University College London Scientists Develop 'Cyborg Engineering' For Coronary Bypass Grafting 6/3/2008
More...
|
Abiomed (ABMD) Receives 510(k) Clearance from FDA for Impella 2.5 Device 6/2/2008
More...
|
Abbott Vascular (ABT) Submits Application for Approval of XIENCE(TM) V Everolimus Eluting Coronary Stent System in Japan 6/2/2008
More...
|
Allon Therapeutics, Inc. Completes Dosing in Phase II Cognitive Impairment Trial 5/23/2008
More...
|
Elixir Medical Announces Positive Nine-Month Results From the Excella Novolimus-Eluting Coronary Stent System First-In-Man Study 4/1/2008
More...
|
Medtronic, Inc. (MDT) Receives FDA Approval for Endeavor(R) Zotarolimus-Eluting Coronary Stent System 2/1/2008
More...
|
Abbott Vascular Devices (ABT) Gains Reimbursement for XIENCE(TM) V Drug Eluting Stent in France 2/1/2008
More...
|
Bypass Better Than Stents For Coronary Disease 1/24/2008
More...
|
Bayer HealthCare Pharmaceuticals (BAY) Issues Additional Guidance to Physicians on Trasylol(R) 10/25/2007
More...
|
Medicure Inc. (MCU) Mulling Early Data Release for Heart Drug Two Months Ahead of Schedule 9/20/2007
More...
|
Cardica, Inc. (CRDC) Receives European CE Mark for C-Port Flex A System for Use in Coronary Artery Bypass Surgery 9/12/2007
More...
|
Northwestern University Study Finds Drug-Coated Stents Safe for Coronary Artery Blockages 5/29/2007
More...
|
Stentys Reports Acute Results of Preclinical Testing With Its Bifurcated Stent 5/29/2007
More...
|
Stentys to Report Acute Results of Preclinical Testing With Its Bifurcated Stent 5/15/2007
More...
|
Medicure Inc. (MCU) Announces Successful DSMB Review for the Phase 3 MEND-CABG II Trial 5/7/2007
More...
|
Risk and Outcome Similar for Bypass Surgery, Drug-Eluting Stents 4/20/2007
More...
|
Angiotech Pharmaceuticals, Inc. (ANPI)'s Corporate Partner, Boston Scientific Corporation (BSX), Announces Japanese Approval for the TAXUS(R) Express2(TM) Stent System 4/3/2007
More...
|
Bone Mineral Loss Seen in Men After Heart Surgery 3/21/2007
More...
|
The Medicines Company (MDCO) Products Angiomax(R) (bivalirudin) and Cleviprex(TM) (clevidipine) Featured in Three Late Breaking Trials at American College of Cardiology Annual Scientific Session 3/15/2007
More...
|
Performing Surgery On A Beating Heart May Be Safer 2/2/2007
More...
|
Allon Therapeutics, Inc. Confirms Progress In AL-208 Phase II Clinical Trial 1/22/2007
More...
|
Implant Sciences Corporation (IMX)' Strategic Partner Receives CE Mark For Its ValecorTM Coronary Stent System 12/20/2006
More...
|
Bayer AG (BAY) Drug Can Cause Kidney Damage, FDA Warns 12/18/2006
More...
|
Cappella To Present A Live Case And Results From Coronary Bifurcation Stent Pre-Clinical Studies At TCT 2006 10/24/2006
More...
|
Data Presented By Independent Physician Panel Confirms Low Rate Of Thrombosis With Medtronic, Inc. (MDT) Endeavor Drug-Eluting Stent 10/24/2006
More...
|
AVI BioPharma, Inc. (AVII) Initiates NEUGENE Antisense Clinical Program In Coronary Artery Bypass Grafting 10/18/2006
More...
|
Alchemia Release: Arixtra(R) Receives Priority Review By The FDA In Acute Coronary Syndromes (ACS) 10/4/2006
More...
|
Bypass Surgery Tops Angioplasty For Sickest Heart Patients 10/2/2006
More...
|
GlaxoSmithKline (GSK) Release: FDA Grants Priority Review For ARIXTRA(R) (fondaparinux sodium) In The Treatment Of Acute Coronary Syndromes 10/2/2006
More...
|
Coronary Surgery - Keeping The Way Clear 9/20/2006
More...
|
Stentys To Present At Medtech Insight And Windhover Information Inc.'s 'In3 Europe' Investor Conference In Brussels, Sept. 18-20, 2006 9/12/2006
More...
|
Abbott Laboratories (ABT)'s New Xience Stent Beats Taxus In Study 9/5/2006
More...
|
Conor Medsystems, Inc. Announces Two-Year Follow-Up Data From EuroSTAR Pivotal Study 9/5/2006
More...
|
Cordis Corporation (JNJ) Release: Study Suggests CYPHER(R) Sirolimus-Eluting Coronary Stent More Cost-Effective Than The Taxus Stent 7/27/2006
More...
|
Boston Scientific Corporation (BSX) Release: OLYMPIA Phase I Registry Demonstrates Efficacy Of TAXUS(R) Liberte(TM) Stent System In Complex Patients And Lesions 7/24/2006
More...
|
Lumen Biomedical, Inc. Announces The Successful Initiation Of Its FiberNet(R) Carotid Embolic Protection US IDE Trial 7/18/2006
More...
|
Cordis Corporation (JNJ) Release: Data Show Overlapping CYPHER(R) Sirolimus-Eluting Coronary Stents Have Better Rates Of Key Clinical Indicators Than Overlapping Bare Metal Stents 7/17/2006
More...
|
diaDexus Release: New Data Published In An American Heart Association Journal Shows That Lipoprotein-Associated Phospholipase A2 Independently Adds To The Diagnostic Accuracy Of Traditional Risk Assessment For Future Cardiovascular Events 6/26/2006
More...
|
Johnson & Johnson (JNJ)'s Cordis Corporation (JNJ) Unit Gets European OK For New Cypher Stent 6/22/2006
More...
|
Cardica, Inc. (CRDC)'s Automated Anastomosis Systems Featured At Major Cardiac Surgery Conference 6/8/2006
More...
|
VIVA Physicians, Inc. Release: FDA Approves First U.S. Study Of Stent Placement To Treat Arterial Blockages Below The Knee 6/1/2006
More...
|
Court Of Appeals Rules Boston Scientific Corporation (BSX)'s Products Do Not Infringe Medtronic, Inc. (MDT) Stent Patents 5/30/2006
More...
|
Conor Medsystems, Inc. Announces First Patient Treated With Dual-Drug Coronary Stent 5/18/2006
More...
|
Angiotech Pharmaceuticals, Inc. (ANPI) Release: TAXUS(R) Liberte(TM) Stent System Receives European Approval For Three Complex Coronary Procedures 5/17/2006
More...
|
Angiotech Pharmaceuticals, Inc. (ANPI) Release: TAXUS ATLAS Trial Supports Superior Deliverability And Proven Outcomes Of TAXUS(R) Liberte(TM) Stent System 5/17/2006
More...
|
Angiotech Pharmaceuticals, Inc. (ANPI) Release: Moderate-Release TAXUS(R) Express(TM) Coronary Stent System Demonstrates Sustained Long-Term Outcomes In High-Risk patients 5/17/2006
More...
|
Cordis Corporation (JNJ) Submits Pre-Market Approval Supplement For Direct Stenting 5/17/2006
More...
|
Cordis Corporation (JNJ) Release: Study Suggests Drug-Eluting Stent Type And Vessel Size Are Important Predictors Of Reblockage In Coronary Artery 5/17/2006
More...
|
Cordis Corporation (JNJ) Release: Physicians Now Have A New Treatment Option For Patients With A Common Vascular Disease Affecting The Legs 5/16/2006
More...
|
Boston Scientific Corporation (BSX) Release: MELODIE Clinical Trial Reports Excellent Safety And Efficacy Results For Express(TM) Vascular LD Stent In The Treatment Of Blocked Iliac Arteries 5/16/2006
More...
|
Boston Scientific Corporation (BSX) Release: Moderate-Release TAXUS(R) Express(TM) Coronary Stent System Demonstrates Sustained Long-Term Outcomes In High-Risk Patients 5/16/2006
More...
|
Boston Scientific Corporation (BSX) Release: TAXUS(R) Liberte(TM) Stent System Receives European Approval For Three Complex Coronary Procedures 5/16/2006
More...
|
Boston Scientific Corporation (BSX) Release: TAXUS ATLAS Trial Supports Superior Deliverability And Proven Outcomes Of TAXUS(R) Liberte(TM) Stent System 5/16/2006
More...
|
Tryton Medical, Inc. Announces First Clinical Use Of Its Side-Branch Stent (TM) To Treat Coronary Bifurcation Lesions 5/15/2006
More...
|
Conor Medsystems, Inc. Initiates RAPID Clinical Study For First Pimecrolimus Drug-Eluting Stent 5/11/2006
More...
|
Boston Scientific Corporation (BSX) To Release Latest Clinical Trial Results On Market-Leading TAXUS(R) Coronary Stent Systems At EuroPCR 5/10/2006
More...
|
Neuren Pharmaceuticals Limited Release: Brain Protectant Drug Successfully Completes Safety Trial 4/27/2006
More...
|
Inspire Pharmaceuticals (ISPH) Announces Initiation Of Phase 2 Clinical Trial Of Platelet Aggregation Inhibitor 4/26/2006
More...
|
Cordis Corporation (JNJ) Release: Two Million Patients Treated With The CYPHER(R) Sirolimus-Eluting Coronary Stent 4/26/2006
More...
|
Kensey Nash Corporation (KNSY) Announces Completion Of Carotid Pilot Trial Using The TriActiv(R) ProGuard(TM) System 4/26/2006
More...
|
Conor Medsystems, Inc. Completes Enrollment Of COSTAR II Pivotal Randomized Drug-Eluting Stent Trial 4/21/2006
More...
|
Neuren Pharmaceuticals Limited Announces Successful Phase 2 Results For Its Lead Candidate Glypromate(R) 4/13/2006
More...
|
Cordis Corporation (JNJ) Release: One-Year Data From World's Largest Completed Drug-Eluting Stent Registry Further Supports Safety And Efficacy Of The Cypher(R) Sirolimus-Eluting Coronary Stent In Complex, Real-World Patients 4/3/2006
More...
|
Conor Medsystems, Inc. Licenses Pimecrolimus From Novartis Pharma AG (NVS) For Use In Next-Generation Reservoir-Based Drug-Eluting Stents 3/16/2006
More...
|
Alexion Pharmaceuticals Inc. (ALXN) Updates Previously Announced Phase III Results For PRIMO-CABG2 Study 3/14/2006
More...
|
Cordis Corporation (JNJ) Release: New Data Suggest Patients With Bifurcation Lesions Experienced Very Low Serious Event Rates With The CYPHER(R) Sirolimus-Eluting Coronary Stent 3/14/2006
More...
|
PeriCor Therapeutics Reports Positive Two-Year Mortality Results Of Acadesine At The American College of Cardiology's Scientific Session 3/13/2006
More...
|
Abbott Laboratories (ABT) Reports Positive Results From First Human Clinical Trial Featuring ZoMaxx(TM) Drug-Eluting Coronary Stent 3/13/2006
More...
|
Boston Scientific Corporation (BSX) Release: STENT Registry Safety Data Favors TAXUS(R) Over Cypher(R) In The Most Complex Diabetic Patients 3/13/2006
More...
|
Cordis Corporation (JNJ) Release: Four-Year Data Suggest The CYPHER(R) Sirolimus-Eluting Coronary Stent Provides Long-Term Efficacy And Safety Benefits With No 'Late Catch-Up' In Restenosis 3/13/2006
More...
|
Cordis Corporation (JNJ) Release: Heart Attack Patients Fare Better With The CYPHER(R) Sirolimus-Eluting Coronary Stent Than A Bare Metal Stent, New Study Finds 3/13/2006
More...
|
Cordis Corporation (JNJ) Release: Newly Published Data Suggest Better Outcomes With The CYPHER(R) Sirolimus-Eluting Coronary Stent Than Brachytherapy In Patients With In-Stent Reblockage 3/13/2006
More...
|
Cordis Corporation (JNJ) Release: New Data Suggest Differences In Clinical Performance Between The CYPHER(R) Sirolimus-Eluting Coronary Stent And The Taxus Stent In Long Complex Lesions 3/13/2006
More...
|
Cordis Endovascular Release: New Data Demonstrate Carotid Artery Stenting In Clinical Practice Has Comparable Major Adverse Event Rate With That Seen In Pivotal SAPPHIRE Trial 3/13/2006
More...
|
ev3 Inc. Announces Global Launch Of New PROTEGE(R) EverFlex(TM) Self-Expanding Stent System 3/10/2006
More...
|
Angiotech Pharmaceuticals (ANPI) Partner Submits Final Module For TAXUS(R) Liberte(TM) Coronary Stent System Application 3/9/2006
More...
|
Cordis Corporation (JNJ) Release: New Clinical Data For The CYPHER(R) Sirolimus-Eluting Coronary Stent In Heart Attacks And Long Lesions To Appear At American College of Cardiology 3/8/2006
More...
|
CardioTech International, Inc. (CTE) Plans Abbreviated Trial For CardioPass Based On Notified Body Response 3/8/2006
More...
|
Allon Therapeutics, Inc.'s AL-208 Product Successful In Phase I Clinical Trial 2/28/2006
More...
|
ev3 Inc. Receives FDA Clearance For SpideRX(TM) Embolic Protection Device For Carotid Artery Stenting 2/20/2006
More...
|
Sorin: Janus Tacrolimus Eluting Carbostent Demonstrates Excellent Safety Profile And Clinical Efficacy In "Real-World" Patients, Particularly In Those With Acute Myocardial Infarction 2/20/2006
More...
|
Conor Medsystems, Inc. Receives CE Mark For CoStar(TM) Drug-Eluting Stent 2/17/2006
More...
|
Boston Scientific Corporation (BSX) Announces French Reimbursement For TAXUS(R) Liberte(TM) Paclitaxel-Eluting Coronary Stent System 2/15/2006
More...
|
FDA Issues Public Health Advisory For Bayer AG (BAY)'s Trasylol; Drug Linked To Higher Risks Of Serious Side Effects 2/8/2006
More...
|
CardioTech International, Inc. (CTE) Begins Process To Obtain An IDE In The U.S. For CardioPass Coronary Graft 1/25/2006
More...
|
Cordis Corporation (JNJ) Release: FDA Approves Updated Instructions For Use For The CYPHER(R) Sirolimus-Eluting Coronary Stent 1/23/2006
More...
|
Cordis Corporation (JNJ) Release: CYPHER(R) Sirolimus-eluting Coronary Stent Benefits From Clinical Success, Worldwide Growth In 2005 12/21/2005
More...
|
Conor Medsystems, Inc. Receives FDA Approval For Full Expansion Of COSTAR II Drug Eluting Stent Trial 12/1/2005
More...
|
Alexion Pharmaceuticals Inc. (ALXN) Reports Phase III Results for PRIMO-CABG2 Study; Drug Trial Fails To Meet Expectations 11/23/2005
More...
|
CABG Medical Inc. Announces Update On Clinical Trial 11/16/2005
More...
|
Cordis Corporation (JNJ) Release: Excellent Results Seen In Study Of Coronary Bifurcations Treated With The CYPHER(R) Sirolimus-Eluting Coronary Stent 11/15/2005
More...
|
OrbusNeich Release: Pro-Healing Coronary Stent Demonstrates Impressive Patient Results 11/8/2005
More...
|
Allon Therapeutics, Inc. Completes Dosing In Phase I Human Clinical Trials For AL-208 Product 10/27/2005
More...
|
Boston Scientific Corporation (BSX) Release: TAXUS(R) Stent Demonstrates Excellent Efficacy And Safety In Independent "STENT" Registry 10/26/2005
More...
|
Teva Pharmaceutical Industries Limited (TEVA) Receives Favorable Court Ruling On Generic Pravachol(R) Exclusivity 10/21/2005
More...
|
Data From CV Therapeutics, Inc. (CVTX) Drug-Eluting Stent Program Presented At TCT Annual Scientific Symposium 2005 10/21/2005
More...
|
Conor Medsystems, Inc. Presents Positive Clinical Data From EuroSTAR And COSTAR I Studies 10/21/2005
More...
|
Boston Scientific Corporation (BSX) Release: OLYMPIA Registry Supports Positive Safety Profile Of TAXUS(R) Liberte(TM) Stent System 10/21/2005
More...
|
Xtent Inc. Announces Early Results Of First-in-Man Trial Of First Customizable Stent 10/21/2005
More...
|
Cordis Corporation (JNJ) Release: Study Finds Excellent Results In Patients With Long Lesions Treated With Multiple And Overlapping CYPHER(R) Sirolimus-Eluting Coronary Stents 10/20/2005
More...
|
Cordis Corporation (JNJ) The CYPHER(R) Sirolimus-Eluting Coronary Stent Outperforms The Taxus Stent In Analysis Of Seven Clinical Trials 10/20/2005
More...
|
Boston Scientific Corporation (BSX) Release: TAXUS Clinical Trial Data Demonstrates Outstanding Long-Term Safety And Efficacy Record 10/19/2005
More...
|
Boston Scientific Corporation (BSX) Study Shows Excellent Performance In High-Risk Patients With Carotid Artery Disease 10/18/2005
More...
|
Medtronic, Inc. (MDT) Stent Misses Target 10/17/2005
More...
|
Cordis Corporation (JNJ) Release: New Study Results Suggest Better Outcomes With the CYPHER(R) Sirolimus-Eluting Coronary Stent Than Brachytherapy In Patients With In-Stent Reblockage 10/17/2005
More...
|
Lumen Therapeutics Announces Completion Of The Phase I Trial And Phase II Development Plans For Lt-1951 - A Potential Treatment For Prevention Of Coronary Artery Bypass Graft (CABG) Failure 10/3/2005
More...
|
Kensey Nash Corporation (KNSY) Announces IDE Submission To Study TriActiv(R) LFX(TM) System In Carotid Stenting Trial 9/23/2005
More...
|
Boston Scientific Corporation (BSX) To Pay Israeli Company Medinol Ltd. $750 Million 9/22/2005
More...
|
Archemix Corporation And Nuvelo, Inc. (NUVO) Close Phase 1 Trial for Thrombin Inhibitor, ARC183 9/22/2005
More...
|
CardioTech International, Inc. (CTE) To Present Paper On CardioPass At I-SECT 9/19/2005
More...
|
Angiotech Pharmaceuticals (ANPI) Release: JAMA Article Says TAXUS Stents Half As Likely To Require Reintervention In Complex Lesions 9/14/2005
More...
|
CABG Medical Inc. Announces Commencement Of Clinical Trials In Europe 9/12/2005
More...
|
Drug Could Cut Heart Surgery Risks 9/9/2005
More...
|
Johnson & Johnson (JNJ) Advised By Canadian Competition Bureau On Proposed Acquisition Of Guidant Corporation (GDT) 9/2/2005
More...
|
Vascular Solutions (VASC) Gets FDA Device OK 8/17/2005
More...
|
Terumo Corporation Completes Twentieth Case Of DuraHeart Artificial Heart Implantation 7/26/2005
More...
|
Medicure Inc. (MCU) Completes Enrollment In MEND-CABG Trial 7/12/2005
More...
|
Singapore-Listed Biosensors International Obtains CE Mark Approval For Axxion Drug-Eluting Stent 7/12/2005
More...
|
Alexion Pharmaceuticals Inc. (ALXN) Reports Results Of Eculizumab Extension Trial In PNH In The Journal Blood 6/29/2005
More...
|
Scott And Scott, LLC Files Initial Securities Fraud Class Action Lawsuit Against Guidant Corporation (GDT) 6/27/2005
More...
|
Jury Finds Cordis Corporation (JNJ) Patents Infringed By Boston Scientific Corporation (BSX) Stents 6/21/2005
More...
|
Boston Scientific Corporation (BSX) Release: Next-Generation TAXUS(R) Liberte(TM) Coronary Stent System Registry Completes First Enrollment Phase 6/20/2005
More...
|
CABG Medical Inc. Announces Approval To Expand Clinical Trials Into Europe 6/3/2005
More...
|
Terumo Europe N.V. Enrolls First Patient In Clinical Trial Of Nobori(TM) Drug-Eluting Coronary Stent 5/27/2005
More...
|
Biosensors International Releases Favourable Preliminary 12-Month Results From Drug-Eluting Stent Trial 5/27/2005
More...
|
Sorin Group Announces Excellent 6-Month Interim Clinical Results Of JANUS Drug-Eluting Stent JUPITER II Trial 5/27/2005
More...
|
Boston Scientific Corporation (BSX) Announces 400th Patient Enrolled In Study Of Next-Generation TAXUS(R) Liberte(TM) Coronary Stent System 5/26/2005
More...
|
EndoTex Interventional Systems, Inc.'s Carotid Artery Stenting Trial (CABERNET) Demonstrates Favorable Outcomes In High-Risk Patients 5/26/2005
More...
|
Cordis Corporation (JNJ) Four-Year Clinical Results From The RAVEL Trial Show Sustained Clinical Benefits With The CYPHER(R) Sirolimus-Eluting Coronary Stent 5/25/2005
More...
|
Conor Medsystems, Inc. Initiates COSTAR II Pivotal Drug-Eluting Stent Clinical Trial In U.S. 5/24/2005
More...
|
FDA Approves 12-Month Shelf Life For TAXUS(R) Stent System 5/23/2005
More...
|
Myogen (MYOG) Initiates Trial Of Ambrisentan In Patients Who Previously Failed Other ERA Therapy 5/20/2005
More...
|
Cardiovascular Systems, Inc. Announces CE Mark For Its Orbital Atherectomy System For The Treatment Of Peripheral Artery Disease 5/19/2005
More...
|
Cordis Corporation (JNJ) Release: CYPHER(R) Sirolimus-Eluting Coronary Stent Clinical Data To Be Featured At 2005 EuroPCR 5/18/2005
More...
|
Abbott Laboratories (ABT) Enrolls First Patient In Pivotal Drug-Eluting Stent Clinical Trial 5/17/2005
More...
|
Nabi Biopharmaceuticals (NABI) Initiates StaphVAX(R) Immunogenicity Study In Orthopedic Surgery Patients In The United Kingdom 5/17/2005
More...
|
IMI International Medical Innovations Inc. (IMI) Release: PREVU(x) Study To Open New Markets 5/10/2005
More...
|
Conor Medsystems, Inc. Receives CE Mark Approval For UniStar(TM) Cobalt Chromium Stent 5/10/2005
More...
|
Angiotech Pharmaceuticals (ANPI) Announces Positive Safety Data 5/4/2005
More...
|
Angiotech Pharmaceuticals (ANPI) Partner Announces First International Trial Of A Paclitaxel-Eluting Stent For Peripheral Artery Disease 5/3/2005
More...
|
CABG Medical Inc. Announces Initiation Of CE Mark Clinical Trial 5/3/2005
More...
|
MIDAS Research Initiates Research Coverage On Estracure Inc. 4/29/2005
More...
|
Boston Scientific Corporation (BSX) Announces Excellent Results In Study Of Patients With Carotid Artery Disease 4/27/2005
More...
|
Corgentech, Inc. (CGTK) Reduces Expenses And Focuses Development Efforts; Slashes Workforce By 45 Percent 4/20/2005
More...
|
Cordis Corporation (JNJ) Release: CYPHER(R) Sirolimus-Eluting Coronary Stent Receives FDA Approval For MRI Scans Immediately Following Implantation 4/20/2005
More...
|
Medicure Inc. (MCU) Announces Successful DSMB Review From Ongoing Phase II/III MEND-CABG Trial 4/19/2005
More...
|
Boston Scientific Corporation (BSX) Announces Acquisition Of TriVascular, Inc. 4/18/2005
More...
|
Kensey Nash Corporation (KNSY) Reports Results From Large European Study For Its TriActiv(R) System 4/18/2005
More...
|
Boston Scientific Corporation (BSX) Announces FDA Approval And Launch Of Liberte(TM) Coronary Stent System 4/14/2005
More...
|
Impulse Dynamics Launches Phase II Heart Failure Investigational Study In The U.S. Evaluating Use Of New Implantable Pulse Generator 4/13/2005
More...
|
Boston Scientific Corporation (BSX) Begins Exclusive International Distribution Of NexStent(TM) Carotid Stent 4/13/2005
More...
|
MIV Therapeutics Inc. (MIVT) Chief Medical Officer Discusses Recently Filed Patents In Online Interview 4/13/2005
More...
|
EndoTex Interventional Systems, Inc. Announces European Approval Of Novel Carotid Stent Delivery System 4/13/2005
More...
|
Boston Scientific Corporation (BSX) Announces Start Of Enrollment In Groundbreaking Clinical Trial Comparing Drug-Eluting Stents To Cardiac Surgery 4/12/2005
More...
|
Novadaq Technologies, Inc. Reports Positive Results In CABG Study 4/12/2005
More...
|
CardioTech International, Inc. (CTE) To Report On CardioPass Graft To Brazilian Surgeons 4/12/2005
More...
|
CardioTech International, Inc. (CTE) Announces Submission Of CE Marking Application For CardioPass Artificial Coronary Artery Bypass Graft 4/8/2005
More...
|
MedicalCV Announces Sales Of The Omnicarbon(R) Mechanical Heart Valve To Cease On April 30, 2005 4/8/2005
More...
|
Angiotech Pharmaceuticals (ANPI) Partner First To Receive FDA Approval Allowing Immediate MRI Exams For Its TAXUS(R) Express(2)(TM) Paclitaxel-Eluting Stent System 4/5/2005
More...
|
CardioTech International, Inc. (CTE) Announces Successful Launch Of Interventional Cardiology Start-Up 4/4/2005
More...
|
IsoTis OrthoBiologics Receives FDA 510(k) Clearance For DynaGraft II 4/4/2005
More...
|
Corgentech, Inc. (CGTK) And Bristol-Myers Squibb Company (BMY) Announce Results From Edifoligide (E2F Decoy) Phase 3 Trial For Coronary Artery Bypass Graft Failure; Failed To Meet The Trial's Primary And Secondary Endpoints 3/30/2005
More...
|
Kensey Nash Corporation (KNSY) Announces Commencement Of ASPIRE Study For New TriActiv(R) FX(TM) Embolic Protection System 3/30/2005
More...
|
Completed Alltracel Pharmaceuticals Plc Pre-Clinical Studies Indicate Significant Longer Term Coronary Health Benefits Of The m.doc(TM) Technology Platform And An Additive Method Of Action To Both Sterols And Statins 3/23/2005
More...
|
Angiotech Pharmaceuticals (ANPI) And CABG Medical Inc. Enter Exclusive License Agreement To Extend Paclitaxel Technology Into Coronary Bypass Surgery 3/23/2005
More...
|
Angiotech Pharmaceuticals (ANPI) First U.S. Drug-Eluting Stent Trial To Treat Peripheral Arterial Disease Enrolls First Patient At Stanford University Medical Center 3/23/2005
More...
|
Conor Medsystems, Inc. Receives Conditional IDE Approval From The FDA To Begin COSTAR II Pivotal Clinical Trial 3/23/2005
More...
|
Lumen Therapeutics Begins Phase I/IIA Trial Of LT-1951 For Prevention Of Coronary Artery Bypass Graft (CABG) Failure 3/22/2005
More...
|
ev3 Inc. Announces Enrollment Has Begun For SpideRX(TM) Embolic Protection Device In Second Phase Of Carotid Clinical Trial 3/22/2005
More...
|
Thoratec Corporation (THOR) Announces Initiation Of Enrollment In HeartMate(R) II Pivotal Trial 3/17/2005
More...
|
Shareholder Class Action Filed Against Cell Therapeutics, Inc. (CTIC) By The Law Firm Of Schiffrin & Barroway, LLP 3/11/2005
More...
|
Bristol-Myers Squibb Company (BMY) And Sanofi-Aventis (France) (SASY.PA) Release: Results From Two Major Clinical Trials Presented At American College Of Cardiology 3/9/2005
More...
|
CV Therapeutics, Inc. (CVTX) Release: Data From ASCOT Study Which Included Perindopril Presented As Late Breaker At American College Of Cardiology Scientific Sessions 2005 3/9/2005
More...
|
Millennium Pharmaceuticals, Inc. (Cambridge, Massachusetts) (MLNM) Release: Data Support The Positive Clinical Benefits Of GP IIb-IIIa Inhibitors And INTEGRILIN(R) (eptifibatide) Injection 3/9/2005
More...
|
Guilford Pharmaceuticals Inc. (GLFD) Release: AGGRASTAT(R) Injection Clinical Data Presented At American College Of Cardiology Annual Meeting 3/8/2005
More...
|
Allon Therapeutics, Inc. Compounds Show Potential To Treat Eye Disease 3/8/2005
More...
|
Conor Medsystems, Inc. Presents Positive 12-Month Results From PISCES First Generation Paclitaxel Drug-Eluting Stent Trial At American College Of Cardiology Scientific Session 3/8/2005
More...
|
Alexion Pharmaceuticals (ALXN) Appoints Dr. Ruedi E. Waeger To Board Of Directors 3/8/2005
More...
|
diaDexus Presents Abstracts At Scientific Sessions 3/8/2005
More...
|
Boston Scientific Corporation (BSX) Announces Completion Of Acquisition Of Advanced Stent Technologies, Inc. 3/7/2005
More...
|
IMI International Medical Innovations (IMI) Release: Growing Evidence That Skin Sterol Is Linked To Hidden Heart Disease 3/7/2005
More...
|
Kensey Nash Corporation (KNSY) Announces CE Mark Approval For New TriActiv(R) FX(TM) Embolic Protection System 3/7/2005
More...
|
Vascular Solutions (VASC) Announces Japanese Approval Of Pronto Extraction Catheter 3/7/2005
More...
|
Conor Medsystems, Inc. Announces Positive Angiographic And Clinical Results For EuroSTAR Drug-Eluting Stent Trial 3/7/2005
More...
|
Boston Scientific Corporation (BSX) Release: Results Of REALITY Trial Reaffirm Safety And Efficacy Of TAXUS(R) Express2(TM) Paclitaxel-Eluting Stent System 3/7/2005
More...
|
Cordis Corporation (JNJ) Release: Arts II Clinical Study Shows Promising Results For The Cypher(R) Sirolimus-Eluting Coronary Stent In Patients With Multi-Vessel Disease 3/7/2005
More...
|
Boston Scientific Corporation (BSX) To Announce Results From Its TAXUS V Drug-Eluting Stent Clinical Trial, Studying Most Challenging Lesions And Highest-Risk Patients 3/3/2005
More...
|
GenVec Inc. (GNVC) Launches Phase IIB Trial In Patients With Severe Coronary Artery Disease 3/2/2005
More...
|
Atrium Medical Corporation Announces CE Approval For The HyperLite(TM) LX Rapid Exchange PTCA Catheter 3/2/2005
More...
|
Guilford Pharmaceuticals Inc. (GLFD) To Announce 2004 Year-End Financial Results On Tuesday, March 1, 2005 3/1/2005
More...
|
Corgentech, Inc. (CGTK) Plans Meeting With FDA To Discuss Registration Strategy Prior To Unblinding Of Phase 3 Trial 2/24/2005
More...
|
Angiotech Pharmaceuticals (ANPI) Partner Announces Start Of Enrollment In World's Largest Drug-Eluting Stent Registry 2/23/2005
More...
|
Boston Scientific Corporation (BSX) Announces Start Of Enrollment In World's Largest Drug-Eluting Stent Registry 2/23/2005
More...
|
Angiotech Pharmaceuticals (ANPI) Partner Announces Completion Of Enrollment In Pivotal Clinical Trial For Next-Generation Paclitaxel-Eluting Coronary Stent System 2/22/2005
More...
|
Boston Scientific Corporation (BSX) Announces Completion Of Enrollment In Pivotal Clinical Trial For Next-Generation Paclitaxel-Eluting Coronary Stent System 2/22/2005
More...
|
Conor Medsystems, Inc. Files Lawsuit To Revoke Angiotech Pharmaceuticals (ANPI) Patent 2/18/2005
More...
|
DISA Vascular's Small-Vessel Heart Stent Receives European Approval 2/17/2005
More...
|
Conor Medsystems, Inc. Announces Positive Six-Month Follow-Up Data From EuroSTAR Pivotal Study 2/17/2005
More...
|